{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:12:43Z","timestamp":1790021563130,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T00:00:00Z","timestamp":1430352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-0726-x","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T07:54:22Z","timestamp":1430294062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Colchicine effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Ying-Ying","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Thumboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bak Siew","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Haaland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balram","family":"Chowbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibhas","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mann Hong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia B","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,30]]},"reference":[{"key":"726_CR1","unstructured":"Murray C, Lopez A. The global burden of disease. 1996."},{"key":"726_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2105\/AJPH.84.3.351","volume":"84","author":"AA Guccione","year":"1994","unstructured":"Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PW, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84:351\u20138.","journal-title":"Am J Public Health."},{"key":"726_CR3","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163\u201396.","journal-title":"Lancet."},{"key":"726_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bone.2011.10.008","volume":"51","author":"J Martel-Pelletier","year":"2012","unstructured":"Martel-Pelletier J, Wildi LM, Pelletier JP. Future therapeutics for osteoarthritis. Bone. 2012;51:297\u2013311.","journal-title":"Bone."},{"key":"726_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.joca.2011.02.018","volume":"19","author":"PG Conaghan","year":"2011","unstructured":"Conaghan PG, Hunter DJ, Maillefert JF, Reichmann WM, Losina E. Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group. Osteoarthritis Cartilage. 2011;19:606\u201310.","journal-title":"Osteoarthritis Cartilage."},{"key":"726_CR6","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1073\/pnas.1012743108","volume":"108","author":"AE Denoble","year":"2011","unstructured":"Denoble AE, Huffman KM, Stabler TV, Kelly SJ, Hershfield MS, McDaniel GE, et al. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci U S A. 2011;108:2088\u201393.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"726_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/joca.2002.0516","volume":"10","author":"SK Das","year":"2002","unstructured":"Das SK, Mishra K, Ramakrishnan S, Srivastava R, Agarwal GG, Singh R, et al. A randomized controlled trial to evaluate the slow-acting symptom modifying effects of a regimen containing colchicine in a subset of patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 2002;10:247\u201352.","journal-title":"Osteoarthritis Cartilage."},{"key":"726_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/art.10455","volume":"47","author":"SK Das","year":"2002","unstructured":"Das SK, Ramakrishnan S, Mishra K, Srivastava R, Agarwal GG, Singh R, et al. A randomized controlled trial to evaluate the slow-acting symptom-modifying effects of colchicine in osteoarthritis of the knee: a preliminary report. Arthritis Rheum. 2002;47:280\u20134.","journal-title":"Arthritis Rheum."},{"key":"726_CR9","first-page":"513","volume":"29","author":"S Aran","year":"2011","unstructured":"Aran S, Malekzadeh S, Seifirad S. A double-blind randomized controlled trial appraising the symptom-modifying effects of colchicine on osteoarthritis of the knee. Clin Exp Rheumatol. 2011;29:513\u20138.","journal-title":"Clin Exp Rheumatol."},{"key":"726_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/art.1780340502","volume":"34","author":"R Altman","year":"1991","unstructured":"Altman R, Alarc\u00f3n G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991;34:505\u201314.","journal-title":"Arthritis Rheum."},{"key":"726_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/ard.16.4.494","volume":"16","author":"JH KELLGREN","year":"1957","unstructured":"KELLGREN JH, LAWRENCE JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494\u2013502.","journal-title":"Ann Rheum Dis."},{"key":"726_CR12","unstructured":"FDA. Online, available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm174315.htm ."},{"key":"726_CR13","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/art.21100","volume":"52","author":"VB Kraus","year":"2005","unstructured":"Kraus VB, Vail TP, Worrell T, McDaniel G. A comparative assessment of alignment angle of the knee by radiographic and physical examination methods. Arthritis Rheum. 2005;52:1730\u20135.","journal-title":"Arthritis Rheum."},{"key":"726_CR14","first-page":"1833","volume":"15","author":"N Bellamy","year":"1998","unstructured":"Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important participant relevant outcomes to antirheumatic drug therapy in participants with osteoarthritis of the hip or knee. J Rheumatol. 1998;15:1833\u201340.","journal-title":"J Rheumatol."},{"key":"726_CR15","first-page":"789","volume":"9","author":"JF Fries","year":"1982","unstructured":"Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9:789\u201393.","journal-title":"J Rheumatol."},{"key":"726_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473\u201383.","journal-title":"Med Care"},{"key":"726_CR17","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.joca.2007.03.017","volume":"15","author":"VB Kraus","year":"2007","unstructured":"Kraus VB, Stabler TV, Kong SY, Varju G, McDaniel G. Measurement of synovial fluid volume using urea. Osteoarthritis. 2007;15:1217\u201320.","journal-title":"Osteoarthritis."},{"key":"726_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/ard.2006.066183","volume":"67","author":"DJ Hunter","year":"2008","unstructured":"Hunter DJ, Lo GH, Gale D, Grainger AJ, Guermazi A, Conaghan PG. The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score). Ann Rheum Dis. 2008;67:206\u201311.","journal-title":"Ann Rheum Dis."},{"key":"726_CR19","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.joca.2007.05.012","volume":"15","author":"HC Charles","year":"2007","unstructured":"Charles HC, Kraus VB, Ainslie M, Hellio Le Graverand-Gastineau MP. Optimization of the fixed-flexion knee radiograph. Osteoarthritis Cartilage. 2007;15:1221\u20134.","journal-title":"Osteoarthritis Cartilage"},{"key":"726_CR20","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4. 2009 http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/About.html . Accessed 28 Apr 2015.21."},{"key":"726_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.joca.2004.02.001","volume":"12","author":"T Pham","year":"2004","unstructured":"Pham T, van der Heijde D, Altman RD, Anderson JJ, Bellamy N, Hochberg M, et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage. 2004; 12:389\u201399.","journal-title":"Osteoarthritis Cartilage."},{"key":"726_CR22","doi-asserted-by":"crossref","unstructured":"Roderick J A Little, Rubin DB. Statistical analysis with missing data. Wiley-Interscience, New Jersey; 2002","DOI":"10.1002\/9781119013563"},{"key":"726_CR23","doi-asserted-by":"crossref","unstructured":"Acheson RM, Collart AB. New Haven survey of joint diseases. XVII. Relationship between some systemic characteristics and osteoarthrosis in a general population. Ann Rheum Dis. 1975; 34:379\u201387","DOI":"10.1136\/ard.34.5.379"},{"key":"726_CR24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/oxfordjournals.aje.a114939","volume":"128","author":"JJ Anderson","year":"1988","unstructured":"Anderson JJ, Felson DT. Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol. 1988;128:179\u201389.","journal-title":"Am J Epidemiol"},{"key":"726_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7326\/0003-4819-109-1-18","volume":"109","author":"DT Felson","year":"1988","unstructured":"Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med. 1988;109:18\u201324.","journal-title":"Ann Intern Med."},{"key":"726_CR26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1136\/ard.51.8.932","volume":"51","author":"JS Schouten","year":"1992","unstructured":"Schouten JS, van den Ouweland FA, Valkenburg HA. A 12\u00a0year follow up study in the general population on prognostic factors of cartilage loss in osteoarthritis of the knee. Ann Rheum Dis. 1992;51:932\u20137.","journal-title":"Ann Rheum Dis."},{"key":"726_CR27","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/ard.2006.063768","volume":"66","author":"E Roddy","year":"2007","unstructured":"Roddy E, Zhang W, Doherty M. Are joints affected by gout also affected by osteoarthritis? Ann Rheum Dis. 2007;66:1374\u20137.","journal-title":"Ann Rheum Dis."},{"key":"726_CR28","first-page":"1108","volume":"35","author":"C Muehleman","year":"2008","unstructured":"Muehleman C, Li J, Aigner T, Rappoport L, Mattson E, Hirschmugl C, et al. Association Between Crystals and Cartilage Degeneration in the Ankle. J Rheumatol. 2008;35:1108\u201317.","journal-title":"J Rheumatol."},{"key":"726_CR29","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3899\/jrheum.130708","volume":"40","author":"A Chhana","year":"2013","unstructured":"Chhana A, Callon KE, Pool B, Naot D, Gamble GD, Dray M, et al. The Effects of Monosodium Urate Monohydrate Crystals on Chondrocyte Viability and Function: Implications for Development of Cartilage Damage in Gout. J Rheumatol. 2013;40:2067\u201374.","journal-title":"J Rheumatol."},{"key":"726_CR30","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/bjp.2008.20","volume":"153","author":"EW Chia","year":"2008","unstructured":"Chia EW, Grainger R, Harper JL. Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine. Br J Pharmacol. 2008;153:1288\u201395.","journal-title":"Br J Pharmacol."},{"key":"726_CR31","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/art.27327","volume":"62","author":"RA Terkeltaub","year":"2010","unstructured":"Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum. 2010;62:1060\u20138.","journal-title":"Arthritis Rheum."},{"key":"726_CR32","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1056\/NEJM197410312911804","volume":"291","author":"CA Dinarello","year":"1974","unstructured":"Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. Colchicine therapy for familial Mediterranean fever. A double-blind trial. N Engl J Med. 1974;291:934\u20137.","journal-title":"N Engl J Med"},{"key":"726_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0049-0172(91)90019-V","volume":"20","author":"E Ben-Chetrit","year":"1991","unstructured":"Ben-Chetrit E, Levy M. Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15\u00a0years. Semin Arthritis Rheum. 1991;20:241\u20136.","journal-title":"Semin Arthritis Rheum."},{"key":"726_CR34","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1542\/peds.2006-1434","volume":"119","author":"T Kallinich","year":"2007","unstructured":"Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics. 2007;119:e474\u201383.","journal-title":"Pediatrics."},{"key":"726_CR35","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","volume":"61","author":"SM Nidorf","year":"2013","unstructured":"Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol. 2013;61:404\u201310.","journal-title":"J Am Coll Cardiol."},{"key":"726_CR36","unstructured":"Food and Drug Administration. Guidance for industry Clinical development programs for drugs devices and biological products intended for the treatment of osteoarthritis FDA document 1999, 7. 1999."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0726-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-0726-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0726-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0726-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T03:47:34Z","timestamp":1566618454000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-0726-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,30]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["726"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-0726-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,30]]},"assertion":[{"value":"23 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"200"}}